about
Spatiotemporal Regulation of Hsp90-Ligand Complex Leads to Immune ActivationIdentification of Candidate Predictors of Lupus FlareModulating the Innate Immune Response to Influenza A Virus: Potential Therapeutic Use of Anti-Inflammatory DrugsThe plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functionsModelling clinical systemic lupus erythematosus: similarities, differences and success storiesSexual dimorphism in autoimmunityTRIM35 negatively regulates TLR7- and TLR9-mediated type I interferon production by targeting IRF7FcγRIIIa-Syk Co-signal Modulates CD4+ T-cell Response and Up-regulates Toll-like Receptor (TLR) ExpressionA meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those withoutGenetic similarities and differences between discoid and systemic lupus erythematosus patients within the Polish populationDistinct proteome pathology of circulating microparticles in systemic lupus erythematosusThe role of neutrophils and NETosis in autoimmune and renal diseases.Targeting of type I interferon in systemic autoimmune diseasesToll-like receptors in systemic lupus erythematosus: potential for personalized treatment.The effect of the autoimmunity-associated gene, PTPN22, on a BXSB-derived model of lupusEpigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils.A retrovirus packages nascent host noncoding RNAs from a novel surveillance pathwayGene Expression Profiles from Disease Discordant Twins Suggest Shared Antiviral Pathways and Viral Exposures among Multiple Systemic Autoimmune Diseases.Toll-like receptors: potential targets for lupus treatmentPathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for interventionC1q protein binds to the apoptotic nucleolus and causes C1 protease degradation of nucleolar proteins.Immune-Mediated Nephropathy and Systemic Autoimmunity in Mice Does Not Require Receptor Interacting Protein Kinase 3 (RIPK3).A pathogenic IFNα, BLyS and IL-17 axis in Systemic Lupus Erythematosus patients.Immune cell profiling to guide therapeutic decisions in rheumatic diseasesAssociation between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus.Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity.Interferon (IFN)-λ is a potential mediator in lupus nephritisAnifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus ErythematosusSupport for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis.Interactions between Type 1 Interferons and the Th17 Response in Tuberculosis: Lessons Learned from Autoimmune Diseases.Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation.Update on the role of plasmacytoid dendritic cells in inflammatory/autoimmune skin diseases.FcγRIIIa Signaling Modulates Endosomal TLR Responses in Human CD4+ T Cells.Systemic lupus erythematosus biomarkers: the challenging quest.Absent in Melanoma 2 proteins in SLE.Regulating STING in health and diseaseThe multiple pathways to autoimmunity.STING-mediated DNA sensing in cancer immunotherapy.New Insights on Platelets and Platelet-Derived Microparticles in Systemic Lupus Erythematosus.The microRNA miR-31 inhibits CD8+ T cell function in chronic viral infection.
P2860
Q26744078-2E90EB8B-9834-4B16-8E26-D88E694F419EQ26795372-76433ECB-F487-453F-9E28-39E4F2104232Q26800158-40B79646-81B7-4983-A485-AA184BC1D4CCQ27023380-51FAD8BE-64CC-4038-96E8-F44AF5C602FAQ28074217-3F2D22DF-39BE-4916-83B3-6063012BFEDEQ28080459-A0D539B0-3B59-4D57-B88E-82E70923D6A0Q28588234-D95BE1B1-DCD4-46E1-A894-4A7036A07804Q30698666-7763CE6B-2B40-4AAF-8BA7-B69560694E41Q31142463-7E86FD88-7E9E-42BE-8D11-687CE0B8DECBQ33799974-2145D2F2-A4EA-43DA-9A35-7B930B4F10DBQ33820385-16B0BE5C-F418-4E20-98F1-1D87C384999AQ33904653-300CCDD3-D0DD-4CF6-B9D0-BE371F5267CDQ34451758-0A9674D3-CA05-4123-976A-9EE187065094Q34650870-E1DCE6A6-10A4-46E0-AF83-4109C83CAD65Q34918378-F8CF1EFC-E13F-4833-A4D3-B6CB1996FFA8Q35187049-CBCDD750-0353-439C-9A73-1B99006C4CCEQ35228751-DE04EF9B-F7D5-41CC-B52E-C5453F141AF2Q35838076-29B59607-F0D4-440F-B6F1-643A0C15D350Q35848152-C452AB7A-4F90-41F4-8ACB-2DD64C9719B0Q35998510-3A179EB8-8C17-43B1-9E43-4B141128B9E3Q36049951-98CCF8B6-3EC9-4CBE-9D99-1C5E76E4A876Q36145022-EFD20DF7-68A8-48F7-A31C-0E959791767DQ36549197-95BF36A4-1EB2-41D9-9CEF-E0AF55CCACD7Q36982828-ACCD6EDE-3F0A-4E5B-A211-4A4AB36A2341Q37140319-48076817-1A08-46FB-803B-BF4440868154Q37153681-95AEB5A2-84D1-43F0-85F3-87F9A970B3E4Q37464013-2AFAE910-5A4D-473B-9FA7-DDF92C648EE3Q37633408-450DC7F6-E654-4DA2-B29B-2033011212E4Q37694044-D3801BBF-ACCC-40AC-9E53-F85B66D57611Q37737549-38699637-A13E-4C55-AF04-88304960065AQ38605015-EDE5E54A-BE30-4116-83F4-264F10066BA5Q38720050-C1B2F020-DEE6-44D1-8E69-4A0F0918659DQ38788604-B99BBCA9-65C9-4745-B421-6A81D8F558B2Q39053118-F9980958-43FA-450A-B5AB-3FCC3CBA2807Q39071091-210F014F-BFEE-47AF-BE4F-BD15D250B4FEQ39360861-54A4F34D-C436-47C9-BBFA-BCD9E32F19CFQ39386100-0906C1F3-C000-49F2-8595-57997E09B0C3Q39389951-8FB78E74-58F7-46E0-90FF-A27C293F4F05Q39440991-76FB6C26-0130-4277-B86B-1D77F201044FQ40191149-F5C51E06-7954-4C83-98BB-1288F183A39D
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Type I interferon in the pathogenesis of lupus.
@ast
Type I interferon in the pathogenesis of lupus.
@en
type
label
Type I interferon in the pathogenesis of lupus.
@ast
Type I interferon in the pathogenesis of lupus.
@en
prefLabel
Type I interferon in the pathogenesis of lupus.
@ast
Type I interferon in the pathogenesis of lupus.
@en
P2860
P356
P1476
Type I interferon in the pathogenesis of lupus.
@en
P2093
Mary K Crow
P2860
P304
P356
10.4049/JIMMUNOL.1002795
P407
P577
2014-06-01T00:00:00Z